Compounded semaglutide and tirzepatide protocols, fully managed. From patient eligibility check to titration to refills — the entire weight loss workflow runs on Build.MD.
Compounded medications are not FDA-approved and are prepared by licensed pharmacies for individual patients.
Clinical protocol, prescribing, and follow-up — all run by Access Plus Medical providers.
Patient completes intake and history. A provider reviews eligibility before anything is prescribed.
Where appropriate, semaglutide or tirzepatide is prescribed and routed to a vetted 503A pharmacy.
Dose titration, check-ins, and refills are managed on schedule, with provider oversight throughout.
Patient completes a branded intake with history and goals.
An Access Plus Medical provider reviews eligibility and prescribes when appropriate.
The prescription is routed to a licensed pharmacy, and the patient is kept updated through fulfillment.
Check-ins, monitoring, and refills run on schedule with oversight throughout.
Compounded semaglutide and tirzepatide are prepared by a licensed 503A pharmacy for an individual patient, after a provider evaluation. Compounded medications are not FDA-approved. Brand-name GLP-1 is available through the Brand GLP-1 program.
We're onboarding a small first cohort. Tell us what you're building — we'll confirm fit before either of us spends more time.
Build.MD is in early access. We're working with a focused group of operators across providers, medspas, fitness, brands, and enterprise before opening broadly. Tell us what you're building; we'll come back within the next business day if there's a fit.